163 related articles for article (PubMed ID: 29277583)
1. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma.
Lee HL; Chiou HL; Wang SS; Hung SC; Chou MC; Yang SF; Hsieh MJ; Chou YE
Urol Oncol; 2018 Apr; 36(4):160.e15-160.e21. PubMed ID: 29277583
[TBL] [Abstract][Full Text] [Related]
2. Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility.
Lau HK; Wu ER; Chen MK; Hsieh MJ; Yang SF; Wang LY; Chou YE
PLoS One; 2017; 12(4):e0176246. PubMed ID: 28426731
[TBL] [Abstract][Full Text] [Related]
3. Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.
Tsay MD; Hsieh MJ; Wang SS; Wang WC; Chou YY; Shih CH; Yang SF; Chou YE
Urol Oncol; 2019 Apr; 37(4):293.e1-293.e9. PubMed ID: 30611644
[TBL] [Abstract][Full Text] [Related]
4. Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development.
Chen CT; Lee HL; Chiou HL; Chou CH; Wang PH; Yang SF; Chou YE
PLoS One; 2018; 13(6):e0198967. PubMed ID: 29889892
[TBL] [Abstract][Full Text] [Related]
5. Association Between Genetic Polymorphisms of WNT1 Inducible Signaling Pathway Protein 1 and Uterine Cervical Cancer.
Lin YH; Hsiao YH; Yang SF; Liu YF; Hsu CF; Wang PH
Reprod Sci; 2018 Nov; 25(11):1549-1556. PubMed ID: 29402200
[TBL] [Abstract][Full Text] [Related]
6. Effect of
Hung SC; Wang SS; Li JR; Chen CS; Yang CK; Chiu KY; Cheng CL; Ou YC; Ho HC; Yang SF
Int J Med Sci; 2018; 15(14):1731-1736. PubMed ID: 30588197
[TBL] [Abstract][Full Text] [Related]
7. Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Li CC; Hsieh MJ; Wang SS; Hung SC; Lin CY; Kuo CW; Yang SF; Chou YE
Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31940762
[TBL] [Abstract][Full Text] [Related]
8. Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer.
Wang Y; Yang SH; Hsu PW; Chien SY; Wang CQ; Su CM; Dong XF; Zhao YM; Tang CH
Medicine (Baltimore); 2019 Nov; 98(44):e17854. PubMed ID: 31689877
[TBL] [Abstract][Full Text] [Related]
9. Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development.
Yang PJ; Hsieh MJ; Hung TW; Wang SS; Chen SC; Lee MC; Yang SF; Chou YE
Int J Environ Res Public Health; 2019 Apr; 16(8):. PubMed ID: 31013794
[TBL] [Abstract][Full Text] [Related]
10. Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features.
Yu YL; Su KJ; Hsieh MJ; Wang SS; Wang PH; Weng WC; Yang SF
PLoS One; 2014; 9(4):e93635. PubMed ID: 24691023
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
Tung MC; Wen YC; Wang SS; Lin YW; Liu YC; Yang SF; Chien MH
Int J Med Sci; 2018; 15(11):1187-1193. PubMed ID: 30123056
[TBL] [Abstract][Full Text] [Related]
12. Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma.
Tsay MD; Hsieh MJ; Lee CY; Wang SS; Chen CS; Hung SC; Lin CY; Yang SF
Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878098
[TBL] [Abstract][Full Text] [Related]
13. Association of Wnt-Inducible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response.
Chen J; Yin JY; Li XP; Wang Y; Zheng Y; Qian CY; He H; Fang C; Wang Z; Zhang Y; Xiao L; Wang SY; Zhang W; Zhou HH; Liu ZQ
Clin Lung Cancer; 2015 Jul; 16(4):298-304.e1-2. PubMed ID: 25656821
[TBL] [Abstract][Full Text] [Related]
14. The relation between Ring Box-1 protein overexpression and tumor grade and stage in bladder urothelial cell carcinoma.
Celik ZE; Kaynar M; Karabagli P; Gergerlioglu N; Goktas S
Cancer Biomark; 2017 Dec; 20(4):389-394. PubMed ID: 28946546
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
16. Distinct microRNA alterations characterize high- and low-grade bladder cancer.
Catto JW; Miah S; Owen HC; Bryant H; Myers K; Dudziec E; Larré S; Milo M; Rehman I; Rosario DJ; Di Martino E; Knowles MA; Meuth M; Harris AL; Hamdy FC
Cancer Res; 2009 Nov; 69(21):8472-81. PubMed ID: 19843843
[TBL] [Abstract][Full Text] [Related]
17. Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.
Weng WC; Huang YH; Yang SF; Wang SS; Kuo WH; Hsueh CW; Huang CH; Chou YE
Tumour Biol; 2016 May; 37(5):6971-7. PubMed ID: 26662954
[TBL] [Abstract][Full Text] [Related]
18. WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients.
Chen J; Yin J; Li X; Wang Y; Zheng Y; Qian C; Xiao L; Zou T; Wang Z; Liu J; Zhang W; Zhou H; Liu Z
Int J Mol Sci; 2014 Nov; 15(11):21011-27. PubMed ID: 25405734
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of WISP1 as a candidate gene for bone mineral density in the Old Order Amish.
Wang X; Salimi S; Deng Z; Perry J; Ryan KA; Li Z; Liu D; Streeten E; Shuldiner AR; Fu M
Sci Rep; 2018 May; 8(1):7141. PubMed ID: 29739999
[TBL] [Abstract][Full Text] [Related]
20. Associations of VEGF-C genetic polymorphisms with urothelial cell carcinoma susceptibility differ between smokers and non-smokers in Taiwan.
Tung MC; Hsieh MJ; Wang SS; Yang SF; Chen SS; Wang SW; Lee LM; Lee WJ; Chien MH
PLoS One; 2014; 9(3):e91147. PubMed ID: 24608123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]